Cargando…
The Effects of a Novel Curcumin Derivative Loaded Long-Circulating Solid Lipid Nanoparticle on the MHCC-97H Liver Cancer Cells and Pharmacokinetic Behavior
PURPOSE: The objective of this study was to develop long-circulating solid lipid nanoparticles (LSLN) containing a novel curcumin (CU) derivative (CU1), to improve CU1ʹs pharmacokinetic behavior and its anti-cancer effects in MHCC-97H liver cancer cells. METHODS: LSLN loaded with CU1 (CU1-LSLN) was...
Autores principales: | Wei, Yumeng, Li, Ke, Zhao, Wenmei, He, Yingmeng, Shen, Hongping, Yuan, Jiyuan, Pi, Chao, Zhang, Xiaomei, Zeng, Mingtang, Fu, Shaozhi, Song, Xinjie, Lee, Robert J, Zhao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123937/ https://www.ncbi.nlm.nih.gov/pubmed/35607705 http://dx.doi.org/10.2147/IJN.S363237 |
Ejemplares similares
-
Formulation of the novel structure curcumin derivative–loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening in vitro
por: Li, Ke, et al.
Publicado: (2022) -
Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo
por: Pi, Chao, et al.
Publicado: (2022) -
Novel Curcumin Derivative-Decorated Ultralong-Circulating Paclitaxel Nanoparticles: A Novel Delivery System with Superior Anticancer Efficacy and Safety
por: Wei, Yumeng, et al.
Publicado: (2022) -
Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
por: Zhao, Wenmei, et al.
Publicado: (2022) -
Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
por: Tian, Miaomiao, et al.
Publicado: (2015)